Testing blood RNA markers for esophagus cancer and Barrett’s
Part of Cancer, Digestive system clinical trials.
This study looks for helpful “RNA markers” found in blood to improve diagnosis in people with Barrett’s esophagus or esophageal cancer. It may help doctors spot disease more reliably, but it requires specific health and treatment conditions and a planned biopsy blood sample process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- You have either Barrett’s esophagus longer than 3 cm, or confirmed esophageal adenocarcinoma (cancer found on biopsy)
- You can understand the study and sign consent
- You are not enrolled in another study that would interfere with this one
- You are not pregnant or breast-feeding
- You do not have severe organ problems (kidney, heart, lung, etc.) and you do not have another current cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple breath and blood test can help doctors better understand gastro-esophageal cancer and Barrett's esophagus. It aims to see if these non-invasive samples can provide useful information for diagnosis and monitoring.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
This trial tests a new risk model to predict if early Barrett's esophagus-related cancer may return. It also looks at how telling patients their risk affects their quality of life and fear of cancer. If you have Barrett's with a small, early cancer, this study may help decide the best follow-up plan for you.
This study looks at how Barrett's esophagus affects your quality of life and fear of cancer. It uses new tests to better predict who might develop esophageal cancer, so you can get the right care sooner.
This study collects blood and biopsy tissue from people who are having an upper endoscopy at UNC for Barrett’s esophagus or esophageal cancer. The samples help researchers build a biorepository to study these conditions and support future research.
This trial studies whether a special blood test can help predict how well treatment will work for people with stage II–IVA esophageal squamous cell carcinoma. It may help doctors identify who is more likely to benefit from therapy, based on changes seen in the blood over time.
Hear when a new Esophageal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.